Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Venture51, recently rebranded as Hinge Capital, is an early-stage venture capital firm that invests in high-growth technology companies, including those in the 'Health & Self' sector. Founded in 2009, the firm operates as a modern venture platform that supports founders through the 'Traction Gap'—the critical period between a seed round and a Series A. While not a biotechnology or pharmaceutical developer itself, Venture51 is active in the healthcare space through its investments in digital health, wellness, and medical technology startups. The firm utilizes its proprietary data science platform, Rehinged, to provide operational support and strategic insights to its portfolio companies. Headquartered in California, Venture51 focuses on partnering with courageous founders to scale disruptive technologies across various vertical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Venture 51.